Skip to content

A study on different surgical procedures for endometrial cancer

A Retrospective Multicenter Real-World Evidence Study of Open, Laparoscopic and Robotic-assisted Staging Surgery for Endometrial Cancer - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/11/060042
Enrollment
8000
Registered
2023-11-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C579- Malignant neoplasm of female genital organ, unspecified

Interventions

Intervention1: NIL: NIL

Sponsors

Intuitive Surgical Pvt. Ltd. India
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subject who was 18 years of age or older at the time of surgery 2. Subject who has undergone any of open, laparoscopic and robotic-assisted staging surgery [total hysterectomy with or without any of the following: (a) bilateral salpingo-oophorectomy, (b) peritoneal cytology/lavage, (c) lymph node dissection, (d) adhesiolysis, (e) sentinel lymph node mapping, (f) omentectomy] for Stages I-III endometrial cancer (Stage I-III, as per 8th Edn, 2017 AJCC TNM and FIGO Surgical Staging Systems for Endometrial Cancer)

Exclusion criteria

Exclusion criteria: 1. Subject who has undergone any of open, laparoscopic and robotic-assisted endometrial resection for Stage IV endometrial cancer (as per 8th Edn, 2017 AJCC TNM and FIGO Surgical Staging Systems for Endometrial Cancer)

Design outcomes

Primary

MeasureTime frame
The primary outcome of this study is to retrospectively assess the perioperative outcomes through discharge and the short-term clinical outcomes from discharge to 90 days after open, laparoscopic, or robotic-assisted staging surgery for endometrial cancerTimepoint: Till discharge, and from discharge to 90 days after surgery

Secondary

MeasureTime frame
The secondary outcome of this study is to retrospectively assess the oncological outcomes, disease-free survival, and overall survival from postoperative day 91 and beyond up to 5 years after open, laparoscopic, or robotic-assisted staging surgery for endometrial cancer Timepoint: From postoperative day 91 and beyond, up to 5 years after surgery

Countries

India

Contacts

Public ContactDr Akhil Dahiya

Intuitive Surgical Pvt. Ltd. India

akhil.dahiya@intusurg.com08045505100

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026